Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
Oral Oncology|August 27, 2019
Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trialRobert Haddad, Joel Guigay, Ulrich Keilholz, et al.
The New England Journal of Medicine|October 11, 2016
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckRobert L Ferris, George Blumenschein, Jerome Fayette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2023
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaSophie Wildsmith, Weimin Li, Song Wu, et al.
Cancers|July 2, 2021
A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography ImagesSimon A Keek, Frederik W R Wesseling, Henry C Woodruff, et al.
The Lancet. Oncology|June 28, 2017
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trialKevin J Harrington, Robert L Ferris, George Blumenschein, et al.
Oral Oncology|July 27, 2019
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancerEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
Critical Reviews in Oncology/Hematology|March 31, 2015
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensusAurora Mirabile, Gianmauro Numico, Elvio G Russi, et al.
The Journal of Clinical Investigation|September 25, 2025
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation doseEmily Ho, Loris De Cecco, Steven A Eschrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS MutationsAlan L Ho, Irene Brana, Robert Haddad, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaAlice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Pageof 30